Smart Inhaler and Remote Asthma Management in Adolescents With Intellectual and Developmental Disabilities

Part of paid clinical trials in Los Angeles, California.

Sponsor: Children's Hospital Los Angeles
Study ID: NCT07746921
Status: Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Asthma in Children
Autism Spectrum Disorder
Developmental Disability
Intellectual Disabilities (F70-F79)

Eligibility Criteria

Sex: ALL
Age: 10 Years - 17 Years
Healthy Volunteers: Not accepted

Interventions

Use of active remote smart inhaler in the home setting — BEHAVIORAL
The application of the remote smart inhaler in active setting to evaluate feasibility, acceptability, and usability on inhaler use proficiency in the home setting.
Use of passive remote smart inhaler in the home setting — BEHAVIORAL
The application of the passive remote smart inhaler to evaluate feasibility, acceptability, and usability on inhaler use proficiency in the home setting.

Study Details

Correct use of daily medications containing inhaled corticosteroids is key for asthma control, yet children with intellectual and developmental disabilities (IDD) face additional barriers to proper inhaler use. Smart inhalers, a novel technology that provides guidance and immediate feedback on inhaler use techniques, have been shown to enhance correct medication administration in the typically developing pediatric population, but their effectiveness has not been evaluated on the pediatric IDD population for remote home use. This study aims to investigate whether daily application of smart inhalers (1) is feasible, acceptable and usable in the IDD population for remote asthma management, (2) improves the rate of medication use and correct medication administration, and (3) results in improvement in lung function. This effort aims to promote better asthma management in the IDD population for remote home use.

Key Dates

First listed: Aug 5, 2026
Start date: Aug 10, 2026
Status verified: Jul 2026
Primary completion: Aug 9, 2027
Completion: Aug 9, 2027

Study Design

Enrollment: 34 participants (estimated)
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Arms

Experimental: Comparator
Standard asthma education arm and passive smart inhaler every day for 8 weeks in the home setting.
Experimental: Intervention
Uses active smart inhaler daily for 8 weeks in the home setting.